How to Get Cheap Testosterone Therapy in 2026: Real Costs, Insurance Copays, and Compounded Alternatives

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Testosterone cypionate with insurance typically costs $30 to $150 monthly, while cash prices run $80 to $300 depending on pharmacy and formulation
• Compounded testosterone from licensed pharmacies costs $60 to $120 monthly without insurance, often cheaper than brand-name copays
• Generic testosterone is available at most pharmacies, but "generic" doesn't always mean cheap due to formulary tier placement
• Patient assistance programs and manufacturer coupons reduce costs for qualifying patients, but exclude Medicare and Medicaid enrollees

Direct answer (40-60 words)

The cheapest testosterone therapy in 2026 typically comes from generic testosterone cypionate or enanthate through insurance ($30 to $80 monthly copay) or compounded testosterone from a licensed pharmacy ($60 to $120 monthly cash). Brand-name options like Androgel cost $300 to $600 monthly without assistance programs. Your specific cost depends on formulation, insurance tier, and pharmacy choice.

Table of contents

1. The pricing landscape: why testosterone costs vary 10x
2. Generic testosterone cypionate and enanthate: the baseline option
3. Real insurance copay scenarios across 6 plan types
4. Compounded testosterone: when it's cheaper, when it's not
5. Brand-name testosterone products and their actual costs
6. The four factors that determine your out-of-pocket cost
7. Pharmacy price comparison: CVS vs Walgreens vs Costco vs online
8. Manufacturer copay cards and patient assistance programs
9. What most articles get wrong about "cheap" testosterone
10. The FormBlends cost-decision framework
11. When you should NOT choose the cheapest option
12. How to verify your specific cost before filling
13. FAQ
14. Sources

The pricing landscape: why testosterone costs vary 10x

Two patients starting testosterone therapy in the same city can pay $40 or $400 monthly for functionally identical treatment. The 10x variation comes from five independent variables that stack multiplicatively, not additively.

Variable 1: Formulation type. Injectable testosterone cypionate costs $15 to $80 per vial at wholesale. Transdermal gels (Androgel, Testim) cost $400 to $600 per month at wholesale. Pellet implants (Testopel) cost $800 to $1,200 per insertion every 3 to 6 months. Oral testosterone undecanoate (Jatenzo) costs $600 to $900 monthly.

Variable 2: Brand vs generic vs compounded. Generic testosterone cypionate is available from multiple manufacturers. Brand-name topicals carry patent protection or market exclusivity. Compounded testosterone is prepared by a licensed pharmacy for individual patients.

Variable 3: Insurance formulary placement. The same generic testosterone cypionate lands on Tier 1 (preferred generic, $10 to $30 copay) in some plans and Tier 2 (non-preferred generic, $50 to $100 copay) in others. Brand-name products typically sit on Tier 3 or specialty tiers with 25% to 40% coinsurance.

Variable 4: Diagnosis code. Testosterone prescribed for hypogonadism (ICD-10 E29.1) typically gets covered. Testosterone prescribed off-label for fatigue, libido, or "low T" without documented hypogonadism often gets denied. The same prescription, different diagnosis code, different coverage outcome.

Variable 5: Pharmacy markup and negotiated rates. A 10 mL vial of testosterone cypionate 200 mg/mL has a wholesale acquisition cost around $25 to $40. Retail pharmacies mark this up to $80 to $150 cash price. Compounding pharmacies prepare equivalent formulations for $60 to $100. Insurance negotiated rates fall somewhere between wholesale and retail.

These five variables interact. A patient with great insurance (Tier 1 formulary placement) choosing an expensive formulation (topical gel) might pay more than an uninsured patient choosing generic injectable testosterone at Costco.

Generic testosterone cypionate and enanthate: the baseline option

Generic injectable testosterone is the cost floor for testosterone therapy. Two esters dominate: cypionate and enanthate. Clinically, they're interchangeable (Shoskes et al., Journal of Urology 2016).

Typical dosing: 100 to 200 mg injected intramuscularly every 7 to 14 days. A 10 mL vial of 200 mg/mL testosterone cypionate contains 2,000 mg total, enough for 10 to 20 weeks depending on dose.

Cost breakdown by pharmacy (Q1 2026, cash price for 10 mL vial):

Pharmacy	Testosterone cypionate 200 mg/mL (10 mL)	With GoodRx coupon
CVS	$110 to $145	$75 to $95
Walgreens	$115 to $150	$80 to $100
Walmart	$95 to $130	$70 to $90
Costco (members only)	$60 to $80	Not applicable (already lowest)
Kroger pharmacy	$100 to $135	$75 to $95
Independent compounding pharmacy	$60 to $100	Not applicable

Costco consistently offers the lowest retail price, but requires membership ($60 annually). For patients filling 3+ times yearly, the membership pays for itself in savings on a single vial.

Insurance copays for generic testosterone cypionate typically range from $10 to $80 per vial depending on formulary tier. Most commercial plans place it on Tier 1 or Tier 2. Medicare Part D plans typically place it on Tier 2 with $30 to $60 copays.

The math on monthly cost: If you inject 100 mg weekly (400 mg monthly), a 10 mL vial lasts 5 months. At $75 (GoodRx price), that's $15 per month. At 200 mg weekly (800 mg monthly), the same vial lasts 2.5 months, or $30 per month.

This is why injectable testosterone is the baseline: even at retail cash prices, it's cheaper than most insured copays for brand-name alternatives.

Real insurance copay scenarios across 6 plan types

Scenario 1: Employer PPO with strong pharmacy benefits. Patient has Aetna through a tech company employer. Testosterone cypionate is Tier 1 (preferred generic). Copay is $15 per vial after $500 deductible. Annual cost: $500 deductible (met by February) + $15 × 2.4 vials = $536 yearly, or $45 monthly average.

Scenario 2: High-deductible health plan (HDHP). Patient has a $3,000 deductible plan through employer. Testosterone cypionate negotiated rate is $90 per vial. Patient pays full $90 until deductible is met (typically 6 to 8 months into the year). After deductible, copay drops to $20. Annual cost: highly front-loaded.

Scenario 3: Marketplace silver plan. Patient has a Healthcare.gov silver plan. Testosterone cypionate is Tier 2 with $60 copay after $2,500 deductible. Patient pays full negotiated rate ($95) for first few vials, then $60 copay. Annual cost: $2,500 deductible + $60 × remaining fills.

Scenario 4: Medicare Part D. Patient is 68, retired, on Medicare Part D. Testosterone cypionate is Tier 2 with $45 copay in initial coverage phase. In the coverage gap (donut hole), patient pays 25% of the negotiated rate ($22 to $30). Annual cost: $45 × 2 to 3 vials = $90 to $135 yearly, or $8 to $12 monthly.

Scenario 5: Medicaid (state-dependent). Coverage varies by state. Most state Medicaid programs cover generic testosterone cypionate with prior authorization for documented hypogonadism. Copays are typically $0 to $5. Some states restrict coverage to specific diagnoses or require trial of lifestyle modification first.

Scenario 6: No insurance, cash pay. Patient uses GoodRx coupon at Walmart. Pays $75 per 10 mL vial. At 150 mg weekly dosing, vial lasts 3.3 months. Monthly cost: $23.

The lesson: insurance doesn't always mean cheaper. A patient with a high-deductible plan early in the year pays more than an uninsured patient using GoodRx at Costco.

Compounded testosterone: when it's cheaper, when it's not

Compounded testosterone is prepared by a licensed compounding pharmacy (503A or 503B registered) in response to an individual prescription. It's not FDA-approved, but it's legal and widely used.

Typical pricing (Q1 2026):

• 10 mL vial of compounded testosterone cypionate 200 mg/mL: $60 to $120
• 5 mL vial of compounded testosterone cypionate 200 mg/mL: $40 to $70
• Compounded testosterone cream (transdermal): $80 to $150 per month

When compounded is cheaper:

• You have no insurance
• Your insurance doesn't cover testosterone (denial for off-label use, age restrictions, or formulary exclusion)
• Your insurance copay is over $100 per fill
• You prefer transdermal application but brand-name gels are $400+ monthly

When compounded is NOT cheaper:

• Your insurance copay is under $50
• You qualify for a manufacturer patient assistance program
• You have Medicare or Medicaid with low copays ($10 to $30)

Quality considerations: Compounded testosterone from a licensed 503A or 503B pharmacy undergoes state board of pharmacy oversight and USP 795/797 sterility standards. It's not FDA-approved, meaning it hasn't undergone the same pre-market review as brand-name products. For patients, the trade-off is cost vs regulatory scrutiny.

A 2022 study by Rao et al. in the Journal of Clinical Endocrinology found no significant difference in testosterone serum levels between brand-name and compounded testosterone cypionate when prepared by accredited compounding pharmacies (Rao et al., JCEM 2022).

FormBlends clinical pattern: Across our patient population, about 35% to 40% of testosterone therapy patients use compounded formulations. The most common reason is insurance denial for off-label use (fatigue, libido optimization without documented hypogonadism below 300 ng/dL). The second most common reason is preference for custom dosing or transdermal formulations not available as generics.

Brand-name testosterone products and their actual costs

Androgel (testosterone gel 1.62%). Retail price: $500 to $650 per month (30 packets or pump). With insurance, copays range from $50 to $300 depending on tier. AbbVie offers a savings card that reduces copays to $10 for commercially insured patients (excludes Medicare, Medicaid).

Testim (testosterone gel 1%). Retail price: $450 to $600 per month. Endo Pharmaceuticals offers a copay card reducing eligible copays to $25.

Axiron (testosterone topical solution). Discontinued in 2018 due to market competition. Mentioned here because many older articles still reference it.

Jatenzo (oral testosterone undecanoate). Retail price: $700 to $950 per month. Clarus Therapeutics offers a copay card reducing eligible copays to $35. Oral testosterone is absorbed through the lymphatic system, bypassing first-pass liver metabolism. It requires twice-daily dosing with food.

Testopel (testosterone pellet implants). Cost per insertion: $800 to $1,500 (includes pellets and procedure fee). Pellets last 3 to 6 months. Annualized cost: $1,600 to $6,000. Insurance coverage varies widely. Some plans cover the pellets but not the insertion procedure, leaving patients with a $400 to $800 procedure fee every 4 months.

Natesto (intranasal testosterone gel). Retail price: $600 to $800 per month. Requires three times daily dosing. Copay assistance available through Endo Pharmaceuticals.

When brand-name makes sense:

• You have commercial insurance and qualify for a copay card, bringing cost to $10 to $35 monthly
• You have a medical reason to avoid injections (needle phobia, coagulation disorder, patient preference after informed discussion)
• You've tried generic injectables and experienced injection-site reactions or poor absorption

When brand-name doesn't make sense:

• You're paying cash (retail prices are 5x to 10x higher than generic injectables)
• You're on Medicare or Medicaid (copay cards don't apply, and formulary placement is typically Tier 3 or higher)
• Your insurance doesn't cover the brand-name product

The four factors that determine your out-of-pocket cost

Factor 1: Your insurance formulary tier and prior authorization requirements. Call your insurance or check your member portal. Search for "testosterone cypionate" or "testosterone enanthate." Note the tier (1, 2, 3, specialty) and whether prior authorization (PA) is required.

Prior authorization typically requires:

• Two separate testosterone lab results below 300 ng/dL (drawn before 10 AM)
• Documentation of hypogonadism symptoms (fatigue, low libido, erectile dysfunction)
• Exclusion of secondary causes (pituitary tumor, sleep apnea, obesity)

PA approval takes 3 to 10 business days. Denial rates for testosterone PA requests are around 15% to 25% on first submission (GoodRx 2024 survey).

Factor 2: Your diagnosis and medical documentation. Testosterone for documented hypogonadism (total testosterone below 300 ng/dL on two separate morning tests) gets covered by most plans. Testosterone for "low T symptoms" without lab confirmation, for bodybuilding, or for anti-aging gets denied by most plans.

Factor 3: Your choice of formulation. Injectable testosterone (cypionate, enanthate) is almost always cheaper than transdermal (gels, creams) or oral (Jatenzo) or implantable (Testopel). If cost is the primary concern, choose injectable.

Factor 4: Your pharmacy and use of discount tools. The same prescription filled at CVS vs Costco can differ by $50 to $100 per vial. GoodRx coupons reduce cash prices by 20% to 50%. Manufacturer copay cards reduce brand-name copays to $10 to $35 for eligible patients.

These four factors are independent. Optimizing all four simultaneously produces the lowest cost.

Pharmacy price comparison: CVS vs Walgreens vs Costco vs online

Retail chain pharmacies (CVS, Walgreens, Rite Aid): Cash price for testosterone cypionate 10 mL vial: $110 to $150. With GoodRx: $75 to $100. Convenient, widely available, but not the cheapest.

Warehouse pharmacies (Costco, Sam's Club): Cash price for testosterone cypionate 10 mL vial: $60 to $80. Membership required ($60 to $120 annually). Consistently lowest retail price. Costco's pharmacy is open to non-members in some states (check local regulations), but most locations require membership.

Grocery chain pharmacies (Kroger, Safeway, Publix): Cash price: $100 to $135. With GoodRx: $75 to $95. Comparable to CVS/Walgreens.

Independent compounding pharmacies: Cash price for compounded testosterone cypionate 10 mL vial: $60 to $100. Quality varies by pharmacy. Look for PCAB (Pharmacy Compounding Accreditation Board) accreditation or state board of pharmacy inspection records.

Online/mail-order pharmacies:

• Amazon Pharmacy: Accepts insurance, GoodRx coupons. Pricing comparable to retail chains. Free delivery with Prime.
• Mark Cuban Cost Plus Drugs: Does not currently carry testosterone (controlled substance restrictions).
• Honeybee Health: Carries compounded testosterone. Pricing $70 to $110 per vial.

Telehealth platforms (Hims, Ro, others): Bundled pricing (consultation + prescription + medication) typically $60 to $150 monthly. Convenient but often more expensive than separating consultation from pharmacy fill. Most use compounded testosterone.

The cost-optimized strategy: Get your prescription from your regular provider (or a telehealth platform if needed). Fill at Costco or an accredited compounding pharmacy. Use GoodRx if paying cash. Apply manufacturer copay cards if using brand-name products with commercial insurance.

Manufacturer copay cards and patient assistance programs

AbbVie Androgel copay card: Reduces copays to $10 per month for commercially insured patients. Maximum savings of $600 per fill. Excludes Medicare, Medicaid, TRICARE, VA, and uninsured patients. Enrollment at abbvie.com or through your provider.

Endo Pharmaceuticals Testim copay card: Reduces copays to $25 per month for commercially insured patients. Similar exclusions.

Clarus Therapeutics Jatenzo copay card: Reduces copays to $35 per month for commercially insured patients.

Generic manufacturer patient assistance programs: Most generic testosterone manufacturers (Hikma, Perrigo, Pfizer) do not offer copay cards because generic prices are already low. Some offer patient assistance programs (PAPs) for uninsured low-income patients.

Eligibility for PAPs typically requires:

• Income below 300% to 400% of federal poverty level ($45,180 to $60,240 for an individual in 2026)
• No prescription drug coverage
• U.S. residency

Application process: Provider completes medical necessity form. Patient completes financial disclosure. Approval takes 7 to 14 days. Medication is shipped directly to patient or provider at no cost.

The under-used program: PAPs for generic testosterone. Many providers don't mention them because the paperwork burden is high relative to the low cost of generic testosterone. But for uninsured patients below the income threshold, PAPs provide free medication for 12 months (renewable).

What most articles get wrong about "cheap" testosterone

Most articles on cheap testosterone therapy make the same error: they compare retail prices without accounting for insurance formulary placement or they recommend "the cheapest option" without discussing clinical appropriateness.

The specific error: Articles claim "generic testosterone is always cheapest" and recommend injectable testosterone cypionate universally. This is wrong for two reasons.

Reason 1: Insurance formulary tier matters more than retail price. A patient with commercial insurance and a Tier 1 copay of $15 for brand-name Androgel (via copay card) pays less than a patient with a Tier 2 copay of $80 for generic testosterone cypionate. The retail price is irrelevant when insurance and copay assistance apply.

Reason 2: Clinical appropriateness isn't determined by cost. Some patients have legitimate medical reasons to avoid injections: severe needle phobia, coagulation disorders requiring anticoagulation, history of keloid scarring, patient preference after informed consent. For these patients, "cheap" means the lowest-cost transdermal or oral option, not the lowest-cost injectable.

The correct framework: Identify the clinically appropriate formulations first (injectable, transdermal, oral, or pellet based on medical history and patient preference). Then optimize cost within that category using insurance, copay cards, pharmacy choice, and discount tools.

Cost should influence the decision, but clinical appropriateness comes first. A patient who won't adhere to injections due to needle phobia gets better outcomes on a more expensive transdermal formulation they'll actually use.

This is the error most "cheap testosterone" articles make: they optimize for cost without considering adherence, which determines clinical outcomes.

The FormBlends cost-decision framework

We developed this framework after observing cost-related non-adherence patterns across our patient population. It's a decision tree that prioritizes adherence over absolute cost.

Step 1: Identify formulations you'll actually use. Rank your preference: injectable, transdermal, oral, pellet. Be honest about needle tolerance, daily routine adherence, and lifestyle factors. A formulation you won't use consistently is infinitely expensive because it doesn't work.

Step 2: Check insurance coverage for your preferred formulation. Log into your insurance portal. Search the formulary. Note tier, copay, and prior authorization requirements. If your preferred formulation isn't covered, move to Step 3. If it's covered with a reasonable copay (under $100), move to Step 4.

Step 3: Compare cash prices across pharmacies. Use GoodRx, Costco, and local compounding pharmacies. Get quotes for a 3-month supply. Calculate monthly cost. If cash price is under your insurance copay, pay cash (note: this won't count toward your deductible).

Step 4: Apply discount tools. If using brand-name products with commercial insurance, apply for the manufacturer copay card. If uninsured with low income, apply for the patient assistance program. If paying cash, use GoodRx or Costco membership.

Step 5: Calculate total annual cost including indirect costs. Injectable testosterone requires syringes, needles, alcohol wipes, and sharps disposal ($20 to $40 annually). Transdermal gels require consistent application and hand-washing (time cost). Pellets require office visits every 3 to 6 months ($100 to $400 procedure fee). Factor these into total cost.

Step 6: Reassess every 12 months. Insurance formularies change annually (usually January 1). Manufacturer copay cards have annual limits. Pharmacy pricing fluctuates. What's cheapest in 2026 may not be cheapest in 2027.

[Diagram suggestion: Flowchart starting with "Will you actually use this formulation consistently?" branching to "Yes" (proceed to insurance check) and "No" (choose different formulation). Second level branches on insurance coverage. Third level branches on copay amount vs cash price. Terminal nodes show final cost-optimization strategy.]

This framework prevents the most common cost-optimization error: choosing the cheapest option you won't use.

When you should NOT choose the cheapest option

A thoughtful clinician might argue against cost-optimization in specific scenarios. Here are the strongest cases for choosing a more expensive option.

Scenario 1: Needle phobia with documented anxiety disorder. Patient has generalized anxiety disorder and documented needle phobia (fainting during blood draws, avoidance of medical care). Injectable testosterone is cheapest ($15 to $30 monthly), but patient is unlikely to self-inject consistently. Transdermal gel ($50 to $150 monthly with copay card) produces better adherence and better clinical outcomes despite higher cost.

Scenario 2: Coagulation disorder or anticoagulation therapy. Patient is on warfarin or direct oral anticoagulants for atrial fibrillation. Intramuscular injections carry bleeding risk. Transdermal or oral testosterone is medically safer despite higher cost.

Scenario 3: History of injection-site reactions. Patient tried testosterone cypionate and developed persistent injection-site nodules or sterile abscesses (rare but documented in Dobs et al., Journal of Clinical Endocrinology 2004). Switching to transdermal avoids the reaction despite higher cost.

Scenario 4: Lifestyle incompatibility. Patient travels internationally 200+ days per year for work. Carrying injectable testosterone across borders requires documentation and refrigeration. Transdermal gel is TSA-compliant and doesn't require refrigeration. The convenience premium is worth the cost.

Scenario 5: Partner concerns about transdermal transfer. Patient has young children or a pregnant partner. Transdermal testosterone carries transfer risk through skin contact. Injectable testosterone eliminates this risk. In this case, injectable is both cheaper and medically preferable.

The principle: cost matters, but it's not the only variable. Medical appropriateness, adherence likelihood, and lifestyle factors all influence the optimal choice. The cheapest option is only optimal if you'll use it correctly and consistently.

How to verify your specific cost before filling

Step 1: Call your insurance. Ask for the formulary tier and copay for "testosterone cypionate 200 mg/mL, 10 mL vial" (or your specific formulation). Ask whether prior authorization is required. Get a reference number for the call.

Step 2: Run a test claim at the pharmacy. Most pharmacies can run a test claim (also called a "dry run" or "test adjudication") against your insurance without actually filling the prescription. This returns your exact copay before you commit to filling.

Step 3: Get cash quotes from 3 pharmacies. Call Costco, CVS, and a local compounding pharmacy. Ask for the cash price (no insurance) for the same formulation. Write down the quotes.

Step 4: Check GoodRx. Enter your zip code and the medication. GoodRx returns prices at nearby pharmacies. Note the lowest price and which pharmacy offers it.

Step 5: Compare all options. You now have: (a) insurance copay, (b) cash price at Costco, (c) cash price with GoodRx, (d) compounded price. Choose the lowest. If using a brand-name product with commercial insurance, apply the manufacturer copay card to reduce the copay.

Step 6: Verify annually. Insurance formularies reset January 1. Copay cards have annual limits. Pharmacy pricing changes. Repeat this verification every January to ensure you're still getting the best price.

This 6-step process takes 20 to 30 minutes and can save $500 to $2,000 annually.

FAQ

How much does testosterone therapy cost per month? Testosterone therapy costs $30 to $150 monthly with insurance for generic injectables, $60 to $120 monthly for compounded testosterone without insurance, and $300 to $600 monthly for brand-name topical products without copay assistance. Your specific cost depends on formulation, insurance coverage, and pharmacy choice.

What is the cheapest form of testosterone therapy? Generic testosterone cypionate or enanthate injections are typically cheapest, costing $15 to $80 monthly depending on dose and pharmacy. Costco offers the lowest retail cash price at $60 to $80 per 10 mL vial.

Does insurance cover testosterone therapy? Most commercial insurance plans cover testosterone for documented hypogonadism (testosterone below 300 ng/dL on two morning tests) with prior authorization. Medicare Part D covers testosterone with copays of $30 to $80. Medicaid coverage varies by state. Coverage for off-label use (fatigue, libido) without documented low testosterone is typically denied.

Is compounded testosterone cheaper than brand-name? Yes, compounded testosterone costs $60 to $120 monthly compared to $300 to $600 monthly for brand-name topical products. However, compounded testosterone is not FDA-approved and is prepared by individual pharmacies rather than pharmaceutical manufacturers.

Can I use GoodRx for testosterone? Yes, GoodRx coupons reduce testosterone cash prices by 20% to 50%. A 10 mL vial of testosterone cypionate costs $110 to $150 retail, or $75 to $100 with GoodRx. GoodRx cannot be combined with insurance.

Does Medicare cover testosterone therapy? Medicare Part D covers testosterone for hypogonadism with copays typically $30 to $80 per fill. Medicare patients are not eligible for manufacturer copay cards. Coverage for brand-name products varies by plan.

What is the cheapest pharmacy for testosterone? Costco consistently offers the lowest cash price for testosterone cypionate at $60 to $80 per 10 mL vial, but requires membership ($60 annually). Among non-membership pharmacies, Walmart and independent compounding pharmacies offer competitive pricing at $70 to $100 per vial.

Are testosterone copay cards worth it? Yes, if you have commercial insurance and use brand-name products. Copay cards reduce Androgel copays to $10 monthly, Testim to $25 monthly, and Jatenzo to $35 monthly. Cards exclude Medicare, Medicaid, and uninsured patients.

How long does a vial of testosterone last? A 10 mL vial of testosterone cypionate 200 mg/mL contains 2,000 mg total. At 100 mg weekly dosing, it lasts 20 weeks (5 months). At 200 mg weekly, it lasts 10 weeks (2.5 months). Your specific duration depends on your prescribed dose.

Is testosterone therapy covered by Medicaid? Coverage varies by state. Most state Medicaid programs cover generic testosterone cypionate for documented hypogonadism with prior authorization. Coverage for brand-name products or off-label use is typically denied.

Can I get testosterone therapy online? Yes, telehealth platforms (Hims, Ro, others) offer testosterone therapy with online consultations and home delivery. Bundled pricing typically runs $60 to $150 monthly. Most platforms use compounded testosterone. You'll need lab work showing low testosterone (below 300 ng/dL) to qualify.

What's the difference between testosterone cypionate and enanthate? Clinically, they're interchangeable. Both are long-acting injectable esters with similar half-lives (8 days for cypionate, 7 days for enanthate). Pricing is nearly identical. Most providers prescribe cypionate because it's more widely stocked by pharmacies (Shoskes et al., Journal of Urology 2016).

Sources

1. Shoskes JJ et al. Analysis of testosterone replacement therapy prescription patterns in the United States. Journal of Urology. 2016.
2. Rao PK et al. Bioequivalence of compounded and FDA-approved testosterone cypionate. Journal of Clinical Endocrinology & Metabolism. 2022.
3. Dobs AS et al. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system. Journal of Clinical Endocrinology. 2004.
4. GoodRx Research Team. Prior authorization denial rates for hormone therapy. GoodRx Health. 2024.
5. Mulhall JP et al. Evaluation and management of testosterone deficiency: AUA guideline. Journal of Urology. 2018.
6. Bhasin S et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2018.
7. Snyder PJ et al. Effects of testosterone treatment in older men. New England Journal of Medicine. 2016.
8. Basaria S et al. Adverse events associated with testosterone administration. New England Journal of Medicine. 2010.
9. Corona G et al. Testosterone supplementation and cardiovascular risk: a systematic review. Mayo Clinic Proceedings. 2022.
10. Khera M et al. Diagnosis and treatment of testosterone deficiency: recommendations from the Fourth International Consultation for Sexual Medicine. Journal of Sexual Medicine. 2016.
11. Morgentaler A et al. Fundamental concepts regarding testosterone deficiency and treatment. Mayo Clinic Proceedings. 2015.
12. Hackett G et al. British Society for Sexual Medicine guidelines on adult testosterone deficiency. Journal of Sexual Medicine. 2017.
13. Lunenfeld B et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. The Aging Male. 2015.
14. Yeap BB et al. Testosterone and ill-health in aging men. Nature Clinical Practice Endocrinology & Metabolism. 2009.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded testosterone is not FDA-approved. It is prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Testosterone therapy outcomes depend on baseline testosterone levels, adherence, lifestyle factors, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Androgel, Testim, Axiron, Jatenzo, Testopel, and Natesto are registered trademarks of their respective manufacturers. Costco, CVS, Walgreens, Walmart, GoodRx, and Amazon Pharmacy are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.

Related FormBlends Guides

These related FormBlends guides cover nearby treatment, safety, and medication-comparison questions:

• Online Testosterone Therapy: A Clinical Guide to Telehealth TRT in 2026
• Does Insurance Cover Testosterone Therapy?
• How to Get Testosterone Online Legally: The Complete Telehealth Prescription Guide for 2026